ACQUIRED · 2022
Who Acquired PathGroup?
GTCR · $1.20B· 9.2× EBITDA
The acquisition
PathGroup was acquired by GTCR in 2022 for $1.20B. The deal was priced at 9.2× EBITDA.
PathGroup at time of acquisition
EBITDA
$130.0M
Deal value
$1.20B
EV / EBITDA
9.2×
Other acquisitions by GTCR
Recent transactions by the same buyer — useful for understanding their playbook and what they typically pay.
- Dentalcorp Holdings Ltd. · 2025 · $2.40B · 11.0× EBITDA
- Caravel Autism Health · 2024 · $310.0M · 15.5× EBITDA
- Experity · 2022 · $1.25B · 19.2× EBITDA
Similar laboratory services acquisitions
- GeneSeek (Neogen Animal Genomics) · acquired by Zoetis in 2026 · $160.0M
- CHS Outreach Laboratory Assets · acquired by Laboratory Corporation of America Holdings in 2025 · $194.5M
- OPKO / BioReference Health (Clinical Diagnostics Business) · acquired by Labcorp in 2025 · $192.5M
- Akoya Biosciences, Inc. · acquired by Quanterix Corporation in 2025 · $286.0M
- Enzo Biochem, Inc. · acquired by Battery Ventures in 2025 · $37.0M
Run a valuation for a similar laboratory services business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the laboratory services calculator →More on laboratory services valuations
- Laboratory Services valuation calculator· head-term variant
- Laboratory Services median multiples· real-deal benchmarks
- How to value a laboratory services· long-form guide
Sourced from Press reporting. Full deal page.
Citation: ExitValue.ai. (2022). PathGroup acquired by GTCR. https://exitvalue.ai/acquired/pathgroup